Data from Pharmawand - Curated by EPG Health - Date added 09 June 2018
AMAG Pharmaceuticals, Inc. announced that the FDA has accepted its New Drug Application (NDA) for bremelanotide, a first-in-class melanocortin 4 receptor agonist designed for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. The Prescription Drug User Fee Act (PDUFA) date for completion of FDA review of the bremelanotide NDA is March 23, 2019. HSDD is the most common type of female sexual dysfunction, affecting approximately six million premenopausal women in the U.S. HSDD is characterized by persistent low sexual desire (or libido) that is associated with distress, often negatively impacting women’s emotional health, intimate relationships, and overall quality of life.
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
CDK 4/6 inhibitors in metastatic breast cancer
The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Chronic Lymphocytic Leukaemia (CLL)
Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more
+ 1 more
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Related Content
SproutPharma receives FDA guidance on flibanserin for Hypoactive Sexual Desire treatment
Sprout Pharmaceuticals announced that their Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the...
Added 5 years ago
Sprout Pharma appeals FDA Complete Response on flibanserin for Hypoactive Sexual Desire Syndrome
Sprout Pharmaceuticals announced that it has received and appealed the FDA Complete Response Letter (CRL) for flibanserin through the Formal...
Added 5 years ago
LibiGel (BioSante Pharma) fails two Phase III trials for Female Sexual Dysfunction
Results from two Phase III studies of LibiGel (testosterone gel)from BioSante Pharmaceuticals, being BLOOM-1 and BLOOM-2 studies for Hypoactive Sexual...
Added 7 years ago
Phase III ROBIN Study of SAGE 217 meets primary endpoints in postpartum depression.- Sage Therapeutics.
Sage Therapeutics reported top-line results from the Phase III ROBIN Study evaluating the effect of SAGE-217 30 mg on depressive...
Added 1 month ago
FDA Advisory Committee votes 17/2 in favour of Zulresso to treat postpartum depression. Sage Therapeutics
Sage Therapeutics announced that the FDA Psychopharmacologic Drugs Advisory Committee (PDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)...
Added 3 months ago
Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analyses.
Purpose: To clarify the efficacy of phosphodiesterase-5 inhibitors (PDE5Is) and selective serotonin reuptake inhibitors (SSRIs) in men with premature ejaculation (PE).
Added 1 year ago
Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial.
Objective: The aim of this study was to evaluate the effect of Lactobacillus rhamnosus HN001 (HN001) given in pregnancy and postpartum on symptoms of maternal depression and anxiety in the postpartum period.
Added 1 year ago
Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism.
Long-term testosterone replacement therapy is mainly monitored by trough levels of serum testosterone (S-T), while urinary testosterone (U-T) is used by forensic toxicology to evaluate testosterone doping.
Added 1 year ago
Media use and insomnia after terror attacks in France.
Direct exposure to traumatic events often precipitates sleep disorders. Sleep disturbance has also been observed amongst those indirectly exposed to trauma, via mass media.
Added 1 year ago
The effects of childhood maltreatment on brain structure in adults with eating disorders.
Objectives: Childhood maltreatment is a non-specific risk factor for eating disorders (EDs). However, so far, no study has assessed the impact of childhood maltreatment on brain structure of adults with EDs.
Added 1 year ago
Blue Blockers and Insomnia
Under entrained conditions, humans maintain a consolidated nocturnal sleep episode that coincides with environmental darkness and endogenous melatonin secretion. Various factors, such as artificial light, can compromise this temporal harmony...
Added 1 year ago
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
This randomized phase III trial studies carboplatin, paclitaxel, and bevacizumab to see how well they work compared to carboplatin, paclitaxel, and placebo in treating patients with stage III or stage IV ovarian epithelial, primary peritoneal, or...
Added 7 months ago
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
The purpose of this study is to determine which patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib.
Added 8 months ago
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
The primary objective of this study is to evaluate efficacy of niraparib as maintenance therapy in patients who have platinum sensitive ovarian cancer as assessed by the prolongation of progression free survival (PFS).
Added 1 year ago
PK Patch 12 Week Continuous Use
Investigators propose a descriptive pharmacokinetic study of the serum hormone levels of estrogen and progesterone with extended use (12 weeks)...
Added 4 years ago
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant...
Added 1 year ago
Antenatal and postnatal mental health: clinical management and service guidance
This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year.
Added 4 years ago
Guidelines on Management of perinatal mood disorders
The guideline provides recommendations based on current evidence for best practice in the management of antenatal and postnatal mood and anxiety disorders, including depression, anxiety and postpartum psychosis.
Added 6 years ago
Eating disorders: recognition and treatment
It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
Added 8 months ago
Comments
You will need to login, to leave a comment.
epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.